Kenya Battles Snakebite Rampage | Firstpost Africa | N18G
Kenya is currently facing an alarming shortage of snake antivenom amid a significant rise in snakebite cases across the country. While the nation receives only 10,000 to 30,000 vials of antivenom annually, experts estimate that at least 100,000 are required to meet the growing demand. Tragically, this shortage has led to devastating consequences, such as in the case of 14-year-old Shukurani Konde Tuva, who lost his leg after being bitten by a puff adder and receiving ineffective treatment. Many Kenyans still rely on traditional beliefs and home remedies, including voodoo and unproven concoctions, due to the high cost and inaccessibility of proper medical care. Antivenom treatments can cost up to $62 per vial, with some patients requiring multiple doses. Experts emphasise the need for urgent awareness, access to affordable antivenom, and investment in research.